{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:30:20Z","timestamp":1787679020794,"version":"build-2784847793"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T00:00:00Z","timestamp":1365638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s40265-013-0037-z","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T08:28:46Z","timestamp":1365582526000},"page":"495-504","source":"Crossref","is-referenced-by-count":53,"title":["Cryptococcal Infections: Changing Epidemiology and Implications for Therapy"],"prefix":"10.1007","volume":"73","author":[{"given":"Ricardo M.","family":"La Hoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,11]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","unstructured":"Baddley JW, Dismukes WE. Cryptococcosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukers WE, editors. Essentials of clinical mycology. 2nd ed. New York: Springer; 2011. p. 207\u201326.","DOI":"10.1007\/978-1-4419-6640-7_12"},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1128\/JCM.16.1.22-29.1982","volume":"36","author":"R Ikeda","year":"1982","unstructured":"Ikeda R, Shinoda T, Fukuzawa Y, et al. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J Clin Microbiol. 1982;36:22\u20139.","journal-title":"J Clin Microbiol"},{"key":"37_CR3","doi-asserted-by":"crossref","unstructured":"Kwon-Chung KJ, Boekhout T, Fell JW, et al. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Trenomellomycetidae). Taxon. 2002;51:804\u2013086.","DOI":"10.2307\/1555045"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/JCM.37.3.838-840.1999","volume":"37","author":"SP Franzot","year":"1999","unstructured":"Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. Grubii: Separate varietal status for Cryptococcus neoformans serotype a isolates. J Clin Microbiol. 1999;37:838\u201340.","journal-title":"J Clin Microbiol"},{"key":"37_CR5","first-page":"463","volume":"4","author":"F Sanfelice","year":"1894","unstructured":"Sanfelice F. Contributo alle morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann Isto Igiene R Univ Roma. 1894;4:463\u201395.","journal-title":"Ann Isto Igiene R Univ Roma"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00002030-200402200-00024","volume":"18","author":"F Dromer","year":"2004","unstructured":"Dromer F, Mathoulin-Pelissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, French Cryptococcosis Study G. Epidemiology of HIV-associated cryptococcosis in France (1985\u20132001): comparison of the pre and post-HAART eras. AIDS. 2004;18:555\u201362.","journal-title":"AIDS"},{"issue":"Suppl 1","key":"37_CR7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","volume":"30","author":"JE Kaplan","year":"2000","unstructured":"Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 1):S5\u201314.","journal-title":"Clin Infect Dis"},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","volume":"36","author":"SA Mirza","year":"2003","unstructured":"Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000. Clin Infect Dis. 2003;36:789\u201394.","journal-title":"Clin Infect Dis"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1097\/00002030-200012010-00019","volume":"14","author":"LJ Elden van","year":"2000","unstructured":"van Elden LJ, Walenkamp AM, Lipovsky MM, Reiss P, Meis JF, de Marie S, et al. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy. AIDS. 2000;14:2787\u20138.","journal-title":"AIDS"},{"issue":"4","key":"37_CR10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","volume":"23","author":"BJ Park","year":"2009","unstructured":"Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS. 2009;23(4):525\u201330.","journal-title":"AIDS"},{"issue":"15","key":"37_CR11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","volume":"22","author":"SD Lawn","year":"2008","unstructured":"Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897\u2013908.","journal-title":"AIDS"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro841","volume":"2","author":"D Mabey","year":"2004","unstructured":"Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nat Rev Microbiol. 2004;2:231\u201340.","journal-title":"Nat Rev Microbiol"},{"key":"37_CR13","unstructured":"WHO. Mapping the landscape of diagnostics for sexually transmitted infections. Key findings and recommendations. UNICEF\/UNDP\/World Bank\/WHO, 2004."},{"issue":"4","key":"37_CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/cir379","volume":"53","author":"MD Lindsley","year":"2011","unstructured":"Lindsley MD, Mekha N, Baggett HC, et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis. 2011;53(4):321\u20135.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"37_CR15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","volume":"53","author":"JN Jarvis","year":"2011","unstructured":"Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53(10):1019\u201323.","journal-title":"Clin Infect Dis"},{"key":"37_CR16","doi-asserted-by":"crossref","unstructured":"Binnicker MJ, Jespersen DJ, Bestrom JE, et al. Comparison of four assays for the detection of cryptococcal antigen. Clin Vaccine Immunol. 2012;19(12):1988\u201390.","DOI":"10.1128\/CVI.00446-12"},{"issue":"8","key":"37_CR17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3283383aeb","volume":"24","author":"JN Jarvis","year":"2010","unstructured":"Jarvis JN, Meintjes G, Wood R, et al. Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme. AIDS. 2010;24(8):1233\u20135.","journal-title":"AIDS"},{"issue":"9","key":"37_CR18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/eri.11.86","volume":"9","author":"M Roy","year":"2011","unstructured":"Roy M, Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther. 2011;9(9):715\u20137.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","volume":"45","author":"R Micol","year":"2007","unstructured":"Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defi c Syndr. 2007;45:555\u20139.","journal-title":"J Acquir Immune Defi c Syndr"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","volume":"48","author":"JN Jarvis","year":"2009","unstructured":"Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis. 2009;48:856\u201362.","journal-title":"Clin Infect Dis"},{"key":"37_CR21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","volume":"51","author":"DB Meya","year":"2010","unstructured":"Meya DB, Manabe YC, Castelnuovo B, et al. Cost-eff ectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4\u00a0+\u00a0cell count\u00a0<\u00a0or\u00a0=\u00a0100 cells\/microL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010;51:448\u201355.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"37_CR22","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/QAI.0b013e31824c837e","volume":"59","author":"R Rajasingham","year":"2012","unstructured":"Rajasingham R, Meya DB, Boulware DR. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J Acquir Immune Defic Syndr. 2012;59(5):e85\u201391.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"37_CR23","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1086\/657405","volume":"51","author":"JN Jarvis","year":"2010","unstructured":"Jarvis JN, Lawn SD, Wood R, et al. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clin Infect Dis. 2010;51(12):1463\u20135.","journal-title":"Clin Infect Dis"},{"key":"37_CR24","doi-asserted-by":"crossref","unstructured":"Jarvis JN, Govender N, Chiller T, et al. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic). 2012;11(6):374\u20139.","DOI":"10.1177\/1545109712459077"},{"key":"37_CR25","doi-asserted-by":"crossref","unstructured":"Rajasingham R, Boulware DR. Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100\u00a0cells\/mcL. Clin Infect Dis. 2012;55(12):1742\u20134.","DOI":"10.1093\/cid\/cis725"},{"key":"37_CR26","doi-asserted-by":"crossref","unstructured":"Chang LW, Phipps WT, Kennedy GE, Rutherford GW. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. Cochrane Database Syst Rev. 2005;3:CD004773.","DOI":"10.1002\/14651858.CD004773.pub2"},{"issue":"12","key":"37_CR27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(11)70245-6","volume":"11","author":"R Parkes-Ratanshi","year":"2011","unstructured":"Parkes-Ratanshi R, Wakeham K, Levin J, et al. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis. 2011;11(12):933\u201341.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"37_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291\u2013322.","journal-title":"Clin Infect Dis"},{"key":"37_CR29","unstructured":"World Health Organization (2011) Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva: World Health Organization. Available: http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241502979_eng.pdf . Accessed 2 Nov 2012."},{"key":"37_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","volume":"337","author":"CM Horst van der","year":"1997","unstructured":"van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15\u201321.","journal-title":"N Engl J Med"},{"key":"37_CR31","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","volume":"363","author":"AE Brouwer","year":"2004","unstructured":"Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet. 2004;363:1764\u20137.","journal-title":"Lancet"},{"key":"37_CR32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","volume":"49","author":"T Bicanic","year":"2009","unstructured":"Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis. 2009;49:702\u20139.","journal-title":"Clin Infect Dis"},{"key":"37_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0002870","volume":"3","author":"F Dromer","year":"2008","unstructured":"Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS ONE. 2008;3:1\u20139.","journal-title":"PLoS ONE"},{"key":"37_CR34","unstructured":"Day JN, Chau TTH, Dung NT, Mai PP, Phu NH, et al. (2011) Combination antifungal therapy for HIV associated cryptococcal meningitis [abstract]. 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, 17\u201320 September 2011; Chicago, IL, United States."},{"issue":"12","key":"37_CR35","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009;48(12):1775\u201383.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"37_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","volume":"54","author":"A Loyse","year":"2012","unstructured":"Loyse A, Wilson D, Meintjes G, et al. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2012;54(1):121\u20138.","journal-title":"Clin Infect Dis"},{"key":"37_CR37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/427213","volume":"40","author":"S Shoham","year":"2005","unstructured":"Shoham S, Cover C, Donegan N, et al. Cryptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2005;40:477\u20139.","journal-title":"Clin Infect Dis"},{"key":"37_CR38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1086\/429329","volume":"40","author":"PG Pappas","year":"2005","unstructured":"Pappas PG. Managing cryptococcal meningitis is about handling the pressure. Clin Infect Dis. 2005;40:480\u20132.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"37_CR39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","volume":"189","author":"PG Pappas","year":"2004","unstructured":"Pappas PG, Bustamante B, Ticona E, et al. Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis. 2004;189(12):2185\u201391.","journal-title":"J Infect Dis"},{"issue":"9","key":"37_CR40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","volume":"26","author":"JN Jarvis","year":"2012","unstructured":"Jarvis JN, Meintjes G, Rebe K, et al. Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS. 2012;26(9):1105\u201313.","journal-title":"AIDS"},{"issue":"1","key":"37_CR41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","volume":"64","author":"CK Muzoora","year":"2012","unstructured":"Muzoora CK, Kabanda T, Ortu G, et al. Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis. J Infect. 2012;64(1):76\u201381.","journal-title":"J Infect"},{"issue":"3","key":"37_CR42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","volume":"50","author":"JC Nussbaum","year":"2010","unstructured":"Nussbaum JC, Jackson A, Namarika D, et al. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Clin Infect Dis. 2010;50(3):338\u201344.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"37_CR43","doi-asserted-by":"crossref","first-page":"e1001316","DOI":"10.1371\/journal.pmed.1001316","volume":"9","author":"R Rajasingham","year":"2012","unstructured":"Rajasingham R, Rolfes MA, Birkenkamp KE, Meya DB, Boulware DR. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2012;9(9):e1001316. doi: 10.1371\/journal.pmed.1001316 .","journal-title":"PLoS Med"},{"key":"37_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"AR Zolopa","year":"2009","unstructured":"Zolopa AR, Andersen J, Komarow L, et al. Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE. 2009;4:1\u201310.","journal-title":"PLoS ONE"},{"issue":"11","key":"37_CR45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","volume":"50","author":"AT Makadzange","year":"2010","unstructured":"Makadzange AT, Ndhlovu CE, Takarinda K, et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis. 2010;50(11):1532\u20138.","journal-title":"Clin Infect Dis"},{"key":"37_CR46","doi-asserted-by":"crossref","unstructured":"Bisson GP, Molefi M, Bellamy S, et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clin Infect Dis. 2013;56(8):1165\u201373.","DOI":"10.1093\/cid\/cit019"},{"key":"37_CR47","doi-asserted-by":"crossref","unstructured":"Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients 2010 data report. Am J Transplant. 2012;12 (Suppl 1):1\u2013156.","DOI":"10.1111\/j.1600-6143.2011.03886.x"},{"issue":"3","key":"37_CR48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.md.0000126760.45299.69","volume":"83","author":"N Singh","year":"2004","unstructured":"Singh N, Husain S, De Vera M, et al. Cryptococcus neoformans infection in patients with cirrhosis. Including liver transplant candidates. Medicine (Baltimore). 2004;83(3):188\u201392.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"37_CR49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/lt.22024","volume":"16","author":"CD Sifri","year":"2010","unstructured":"Sifri CD, Sun HY, Cacciarelli TV, et al. Pretransplant cryptococcosis and outcome after liver transplantation. Liver Transpl. 2010;16(4):499\u2013502.","journal-title":"Liver Transpl"},{"issue":"1","key":"37_CR50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/TP.0b013e318236cd1a","volume":"93","author":"N Singh","year":"2012","unstructured":"Singh N, How I. Treat cryptococcosis in organ transplant recipients. Transplantation. 2012;93(1):17\u201321.","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"37_CR51","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1111\/j.1600-6143.2009.02889.x","volume":"9","author":"PA Grossi","year":"2009","unstructured":"Grossi PA, Fishman JA, AST Infectious Disease Community of Practice. Donor-derived infections in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S19\u201326.","journal-title":"Am J Transplant"},{"issue":"5 Suppl","key":"37_CR52","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/TP.0b013e3182481347","volume":"93","author":"PA Grossi","year":"2012","unstructured":"Grossi PA, Costa AN, Fehily D, et al. Infections and organ transplantation: new challenges for prevention and treatment\u2014a colloquium. Transplantation. 2012;93(5 Suppl):S4\u201339.","journal-title":"Transplantation"},{"issue":"5","key":"37_CR53","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/cid\/cis519","volume":"55","author":"JA Fishman","year":"2012","unstructured":"Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis. 2012;55(5):720\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"37_CR54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/656584","volume":"51","author":"HY Sun","year":"2010","unstructured":"Sun HY, Alexander BD, Lortholary O, et al. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis. 2010;51(9):1062\u20139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"37_CR55","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/cid\/ciq216","volume":"52","author":"JW Baddley","year":"2011","unstructured":"Baddley JW, Schain DC, Gupte AA, et al. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis. 2011;52(4):e94\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"37_CR56","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","volume":"50","author":"PG Pappas","year":"2010","unstructured":"Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101\u201311.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"37_CR57","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1111\/j.1600-6143.2009.02911.x","volume":"9","author":"N Singh","year":"2009","unstructured":"Singh N, Forrest G. AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S192\u20138.","journal-title":"Am J Transplant"},{"issue":"8","key":"37_CR58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.tp.0000173774.74388.49","volume":"80","author":"N Singh","year":"2005","unstructured":"Singh N, Lortholary O, Alexander BD, et al. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation. 2005;80(8):1033\u20139.","journal-title":"Transplantation"},{"issue":"5","key":"37_CR59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","volume":"33","author":"PG Pappas","year":"2001","unstructured":"Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33(5):690\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"37_CR60","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijid.2004.12.004","volume":"10","author":"S Kiertiburanakul","year":"2006","unstructured":"Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, et al. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis. 2006;10(1):72\u20138.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"37_CR61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7883\/yoken.JJID.2008.111","volume":"61","author":"U Jongwutiwes","year":"2008","unstructured":"Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis. 2008;61(2):111\u20135.","journal-title":"Jpn J Infect Dis"},{"issue":"5\u20136","key":"37_CR62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11046-011-9471-1","volume":"173","author":"C Yuchong","year":"2012","unstructured":"Yuchong C, Fubin C, Jianghan C, et al. Cryptococcosis in China (1985\u20132010): review of cases from Chinese database. Mycopathologia. 2012;173(5\u20136):329\u201335.","journal-title":"Mycopathologia"},{"key":"37_CR63","doi-asserted-by":"crossref","unstructured":"Ecevit IZ, Clancy CJ, Schmalfuss IM, et al. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. 2006;42:1443\u20137.","DOI":"10.1086\/503570"},{"issue":"6","key":"37_CR64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11046-011-9398-6","volume":"171","author":"SX Wu","year":"2011","unstructured":"Wu SX, Guo NR, Li XF, et al. Human pathogenic fungi in China\u2014emerging trends from ongoing national survey for 1986, 1996, and 2006. Mycopathologia. 2011;171(6):387\u201393.","journal-title":"Mycopathologia"},{"issue":"6","key":"37_CR65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0031-1295720","volume":"32","author":"KD Brizendine","year":"2011","unstructured":"Brizendine KD, Baddley JW, Pappas PG. Pulmonary cryptococcosis. Semin Respir Crit Care Med. 2011;32(6):727\u201334.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"37_CR66","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/infdis\/160.5.912","volume":"160","author":"S Shaunak","year":"1989","unstructured":"Shaunak S, Schell WA, Perfect JR. Cryptococcal meningitis with normal cerebrospinal fluid. J Infect Dis. 1989;160(5):912.","journal-title":"J Infect Dis"},{"issue":"4","key":"37_CR67","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1567-1364.2006.00088.x","volume":"6","author":"KJ Kwon-Chung","year":"2006","unstructured":"Kwon-Chung KJ, Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res. 2006;6(4):574\u201387.","journal-title":"FEMS Yeast Res"},{"key":"37_CR68","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/JCM.34.5.1253-1260.1996","volume":"34","author":"TC Sorrell","year":"1996","unstructured":"Sorrell TC, Chen SC, Ruma P, et al. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol. 1996;34:1253\u201360.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"37_CR69","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/597306","volume":"199","author":"EJ Byrnes 3rd","year":"2009","unstructured":"Byrnes EJ 3rd, Bildfell RJ, Frank SA, et al. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis. 2009;199(7):1081\u20136.","journal-title":"J Infect Dis"},{"key":"37_CR70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.15.3.535-537.1982","volume":"15","author":"KJ Kwon-Chung","year":"1982","unstructured":"Kwon-Chung KJ, Polacheck I, Bennett JE. Improvedm ediumf or separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982;15:535\u20137.","journal-title":"J Clin Microbiol"},{"key":"37_CR71","first-page":"213","volume":"257","author":"KJ Kwon-Chung","year":"1984","unstructured":"Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl. Bakteriol. Mikrobiol Hyg A. 1984;257:213\u20138.","journal-title":"Zentralbl. Bakteriol. Mikrobiol Hyg A"},{"issue":"1","key":"37_CR72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.aje.a113861","volume":"120","author":"KJ Kwon-Chung","year":"1984","unstructured":"Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol. 1984;120(1):123\u201330.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"37_CR73","first-page":"792","volume":"43","author":"C Stephen","year":"2002","unstructured":"Stephen C, Lester S, Black W, et al. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002;43(10):792\u20134.","journal-title":"Can Vet J"},{"key":"37_CR74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","volume":"16","author":"E Galanis","year":"2010","unstructured":"Galanis E, MacDougall L. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007. Emerg Infect Dis. 2010;16:251\u20137.","journal-title":"Emerg Infect Dis"},{"key":"37_CR75","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid1301.060827","volume":"13","author":"L MacDougall","year":"2007","unstructured":"MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007;13:42\u201350.","journal-title":"Emerg Infect Dis"},{"key":"37_CR76","first-page":"865","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Emergence of Cryptococcus gattii\u2014Pacific Northwest, 2004\u20132010. MMWR Morb Mortal Wkly Rep. 2010;59:865\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"37_CR77","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","volume":"53","author":"JR Harris","year":"2011","unstructured":"Harris JR, Lockhart SR, Debess E, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011;53(12):1188\u201395.","journal-title":"Clin Infect Dis"},{"key":"37_CR78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","volume":"31","author":"S Chen","year":"2000","unstructured":"Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31:499\u2013508.","journal-title":"Clin Infect Dis"},{"key":"37_CR79","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinids\/20.3.611","volume":"20","author":"DH Mitchell","year":"1995","unstructured":"Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, Richards MJ, Gottlieb T. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20:611\u20136.","journal-title":"Clin Infect Dis"},{"key":"37_CR80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","volume":"21","author":"B Speed","year":"1995","unstructured":"Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28\u201334.","journal-title":"Clin Infect Dis"},{"key":"37_CR81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","volume":"17","author":"L MacDougall","year":"2011","unstructured":"MacDougall L, Fyfe M, Romney M, Starr M, Galanis E. Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis. 2011;17:193\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"37_CR82","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/cid\/cir738","volume":"53","author":"KA Marr","year":"2011","unstructured":"Marr KA. Cryptococcus gattii: the tip of the iceberg. Clin Infect Dis. 2011;53(12):1196\u20138.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"37_CR83","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/cid\/cir1019","volume":"54","author":"JR Harris","year":"2012","unstructured":"Harris JR, Lockhart SR, Chiller T. Letter re: Marr editorial. Clin Infect Dis. 2012;54(7):1038\u20139.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"37_CR84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01216-08","volume":"53","author":"GR Thompson 3rd","year":"2009","unstructured":"Thompson GR 3rd, Wiederhold NP, Fothergill AW, et al. Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Antimicrob Agents Chemother. 2009;53(1):309\u201311.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"37_CR85","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.01505-09","volume":"48","author":"N Iqbal","year":"2010","unstructured":"Iqbal N, DeBess EE, Wohrle R, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol. 2010;48(2):539\u201344.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"37_CR86","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.00746-10","volume":"54","author":"F Hagen","year":"2010","unstructured":"Hagen F, Illnait-Zaragozi MT, Bartlett KH, et al. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother. 2010;54(12):5139\u201345.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"37_CR87","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","volume":"48","author":"HS Chong","year":"2010","unstructured":"Chong HS, Dagg R, Malik R, et al. In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol. 2010;48(11):4115\u201320.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"37_CR88","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","volume":"56","author":"A Espinel-Ingroff","year":"2012","unstructured":"Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, et al. Cryptococcus neoformans\u2013Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother. 2012;56(6):3107\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"37_CR89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/13693786.2011.602126","volume":"50","author":"L Trilles","year":"2012","unstructured":"Trilles L, Meyer W, Wanke B, et al. Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans\/C. gattii species complex. Med Mycol. 2012;50(3):328\u201332.","journal-title":"Med Mycol"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0037-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-013-0037-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-013-0037-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:18:10Z","timestamp":1715188690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-013-0037-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,11]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s40265-013-0037-z","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,11]]}}}